Kenneth Ng
Scientist I at EpiBiologics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
EpiBiologics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Scientist I
-
Oct 2022 - Present
-
-
-
Soteria Biotherapeutics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Associate Scientist, Immuno-Oncology
-
Jun 2021 - Aug 2022
Building the next generation of T-cell engaging immunotherapies for solid tumors through conditional activation by developing in vitro/in vivo/ex vivo assays to prove efficacy and mechanism of action. Building the next generation of T-cell engaging immunotherapies for solid tumors through conditional activation by developing in vitro/in vivo/ex vivo assays to prove efficacy and mechanism of action.
-
-
-
University of California, San Francisco
-
United States
-
Higher Education
-
700 & Above Employee
-
Research Specialist
-
2017 - 2021
Developing methods to investigate how tumor heterogeneity influences cancer evolution, the immune response, and the response to immunotherapy. Developing methods to investigate how tumor heterogeneity influences cancer evolution, the immune response, and the response to immunotherapy.
-
-
-
Washington University in St. Louis
-
United States
-
Higher Education
-
700 & Above Employee
-
Research Technician
-
2013 - 2016
Genetic engineering of cells for broad applications in manufacturing and disease prevention. High-throughput design and functional screening to create new functions in bacteria, and developing strategies to make sure these new abilities are easy to control and stable over time. Genetic engineering of cells for broad applications in manufacturing and disease prevention. High-throughput design and functional screening to create new functions in bacteria, and developing strategies to make sure these new abilities are easy to control and stable over time.
-
-
Education
-
The Cooper Union for the Advancement of Science and Art
BEng, Chemical Engineering